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Background: Distress and/or dysfunction are well established as key reasons for help-seeking. We explore the
characteristics of groups defined by high or low distress or disability in young people with unipolar depression (UP)
or bipolar disorder (BD).
Methods: Individuals aged 12 to 25 years presenting to youth mental health services for the first time with a
primary diagnosis of UP or BD were assessed using the Kessler Psychological Distress Scale (Kessler-10) and the
Work and Social Adjustment Scale (WSAS). Four groups with high or low distress or impairment were defined
(according to scores above or below the group medians for the Kessler-10 and WSAS). Multinomial logistic
regression (MNLR) was used to examine how cases with high levels of distress and disability (reference group)
differed from the other three groups.
Results and discussion: The sample comprised 1,746 cases (90% UP, 56% female) with a median age of 17.5 years.
Median scores on the Kessler-10 and WSAS were both high (30 and 20, respectively) and were significantly
inter-correlated (r = 0.62); the high impairment/distress group was the largest sub-group (39% of cases). The MNLR
analysis demonstrated that younger age was associated with lower impairment groups (irrespective of distress level),
whilst male gender was associated with lower distress (irrespective of impairment). Compared to the low
impairment/distress cases, the high impairment/distress group was significantly more likely to use cannabis and/or
alcohol. Age, substance use and possibly gender are probably better predictors of distress/impairment sub-group
than mood disorder sub-type in youth.
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In recent decades, there has been a steady increase in
the provision of early intervention services for young
adults at risk of or in the early stages of psychosis. This
has shed light on the reasons why some individuals with
psychotic, mood or other mental disorders seek help,
whilst other young people do not. For example, youth
with psychosis or psychotic-like experiences are more
likely to access clinical services if they perceive a greater
need for care (because of a decline in personal function-
ing) and/or because they wish to ameliorate the distress
associated with acute symptoms (Stip and Letourneau
2009; Yung et al. 2006). These clinical studies indicate* Correspondence: ian.hickie@sydney.edu.au
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in any medium, provided the original work is pthat the reasons for presentation are dictated more by
distress and dysfunction than by diagnosis alone. Further
support for this hypothesis derives from a large-scale
community health survey of more than 36,000 people
aged ≥15 years that identified that seeking treatment
was prompted by increasing levels of disability, distress
and/or suicidal ideation and that these factors operated
across diagnostic and socio-demographic groups (Sareen
et al. 2005).
There are fewer studies of the clinical profile of youth
presenting to care services with a mood disorder, but
data on middle-aged adults with unipolar depression
(UP) and bipolar disorder (BD) suggest that distress is a
robust predictor of help-seeking (Angst et al. 2010;
Mojtabai et al. 2002). Impairment also increases the like-
lihood of presentation to clinical services by older
people, especially in those with co-existing substanceopen access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Scott et al. International Journal of Bipolar Disorders 2013, 1:23 Page 2 of 8
http://www.journalbipolardisorders.com/content/1/1/23misuse or sub-threshold syndromes (Elhai and Ford
2007; Murphy et al. 2010). However, those studies do
not enable us to understand whether young people pre-
senting with BD demonstrate similar patterns of distress
and/or impairment to those reported by individuals with
UP. Further, it is not clear if disability in youth is inde-
pendent of or directly correlated with distress, nor do
we have evidence about the characteristics of individuals
with high levels of distress but low levels of impairment
or vice versa.
A major barrier to understanding the issues outlined
has been the lack of access to samples of adequate size
or that are truly representative of youth who are seeking
help for unipolar or bipolar mood or other mental disor-
ders at the time of first clinical presentation. In 2006,
the Australian Government launched ‘headspace’ ser-
vices in order to extend access to mental health care for
young people aged 12 to 25 years (McGorry et al. 2007).
Besides the clinical and social benefits of this initiative,
there are also opportunities for research on emerging
mood problems. In Sydney, preliminary studies of young
people presenting to two headspace services highlighted
that social impairments exist in the early, sub-syndromal
stages of mood disorders (Hamilton et al. 2011) and that
young people with psychotic, mood and/or anxiety disor-
ders present with significant levels of distress (Scott et al.
2012). Also, a recent multi-site study (sample >2,000)
identified that young people aged 12 to 30 years re-
ported high lifetime rates of alcohol (76%), nicotine
(62%) and cannabis use (54%), with the age at first con-
sumption (mean ~ 15 years) preceding clinical presentation
with a specific mental health problem by about 4 years
(Hermens et al. 2013).
This study examined the levels of distress and impair-
ment in over 1,600 individuals presenting to youth men-
tal health services with a primary diagnosis of UP or BD
and explored which combination of demographic, clin-
ical and substance use parameters identified cases with
high or low levels of distress and/or high or low levels of
functioning.
Methods
The Human Research Ethics Committee (University of
Sydney) approved this study, and all patients gave pro-
spective written informed consent for their clinical data
to be used for research purposes. Parental consent was
obtained for patients under 16 years of age. Patients who
did not wish to participate were not required to explain
withholding consent.
Participants
Consecutive consenting cases aged 12 to 25 years who
presented at two youth-specific mental health clinics
with a probable primary diagnosis of UP or BD wererecruited to the study between October 2007 and
January 2012. Exclusion criteria were as follows: med-
ical instability (as determined by a psychiatrist), lack of
capacity to give informed consent, history of neurological
disease (e.g. tumour, head trauma, epilepsy), medical
illness known to impact cognitive and brain function
(e.g. cancer) and/or clinically assessed IQ below 70
and/or insufficient English to participate in the re-
search protocol.
Assessments
Each referral participated in the interview-based intake
procedure. As described previously (for full details, see
Hamilton et al. 2011; Scott et al. 2012), as well as the
standard clinical assessments, the assessing clinicians
also completed a structured pro forma. This information
was used to confirm the clinical diagnosis; any cases
where diagnosis was uncertain were discussed in a con-
sensus meeting that included senior experts in early on-
set mood disorders (IH and ES); any diagnoses recorded
were also regularly checked for accuracy by a senior re-
searcher (i.e. by DH), furthermore. For this study, the
following data were used:
1. Socio-demographics: age at presentation, gender,
vocational status (defined as being in employment,
education or training: full time, part time or
vocationally inactive)
2. Diagnostic and Statistical Manual, 4th Edition (DSM
IV) mood disorder diagnosis (UP or BD sub-type)
and any lifetime co-morbidities meeting DSM IV
criteria (defined as none, any anxiety disorder, any
behavioural or developmental disorder, any other
co-morbidity) (American Psychiatric Association
2000). In addition, the presence or absence of
psychotic symptoms was noted (as a separate item).
As suicidal ideation may be a significant contributor
to distress, this was assessed on a 0 to 3 scale using
the format employed in depression rating scales
such as the Hamilton (no ideation to suicidal acts)
3. Alcohol and substance use: the frequency of use and
misuse (of alcohol, nicotine, cannabis,
amphetamines, etc.) for the previous 3 months was
assessed from the data recorded on the Alcohol,
Smoking and Substance Involvement Screening Test
(ASSIST; Humeniuk et al. 2008). Data on age at first
consumption (if available) and use of or abstinence
from cannabis and/or nicotine and/or alcohol were
examined in this study
4. Kessler-10 Psychological Distress Questionnaire
(Kessler and Mroczek 1992; Kessler et al. 2002;
Andrews and Slade 2001): This well-validated
10-item questionnaire has been widely used in
community and clinical settings and has been
Scott et al. International Journal of Bipolar Disorders 2013, 1:23 Page 3 of 8
http://www.journalbipolardisorders.com/content/1/1/23applied to a range of diagnoses and clinical
presentations in adolescent and adult populations.
Each Kessler-10 question refers to the preceding
month and is rated on a 1 to 5 scale (from none of
the time to all of the time), and the total score
ranges from 10 to 50, with higher scores indicating
higher levels of distress and scores >30 associated
with severe mental disorders (only about 2% general
population score >29). Its utility is that it measures
distress associated with symptoms rather than
focusing on the symptoms associated with one
specific disorder
5. Work and Social Adjustment Scale (WSAS; Mundt
et al. 2002): The WSAS is a 5-item self-rated
questionnaire that asks the patient to rate key
aspects of their current functioning (ability to work,
home management, social leisure, private leisure and
close relationships over the preceding 4 weeks).
The scale has been used previously in those with
more severe mental disorders (Mundt et al. 2002)
and has been found to have good psychometric
properties (Mundt et al. 2002; Mataix-Colsa et al.
2005). Each item is rated on a 0 to 8 scale (from
‘not at all’ to ‘severely affected’), and a total score
of >20 is regarded as indicating high levels of
impairment.
Statistical analyses
All data were entered into a study database and analysed
using SPSS version 19. Analysis of variance (ANOVA)
with Dunnett’s post hoc tests was used to test for signifi-
cant differences in mean age (across groups). Pearson
product moment correlations were used to examine for
significant associations between scores of distress and
disability, with partial correlations testing the associa-
tions when controlling for age, gender and diagnostic
sub-type. Differences for categorical measures between
groups (e.g. gender, diagnosis, vocational status, ASSIST
ratings) were assessed using chi-squared tests. Cases
with missing data were excluded list-wise from the ana-
lyses. All statistical tests were two-tailed and used a sig-
nificance level of α = 0.05.
Multinomial logistic regression (MNLR) was used to
examine for demographic and clinical predictors of
membership of four groups defined by a combination of
high and/or low levels of impairment or distress (cat-
egories were defined by scores above or below the me-
dian for the Kessler-10 or WSAS). The largest group
(which was the one with the highest level of impairment
and distress) was selected as the reference category, and
the forward (likelihood ratio) procedure was used for the
regression. Variables were entered into the model if they
had a significance level <0.05. The factors and variables
included were as follows: age (split into categoriesaccording to ‘terciles’), gender, mood disorder sub-type
(BD vs UP), ASSIST ratings of the frequency of nicotine,
cannabis and alcohol use (5-point rating: never, 1 to
2 occasions, monthly, weekly, daily) and the presence
or absence of co-morbidities. Predictors of sub-group
membership are reported using odds ratios (OR) with
95% confidence intervals (CI).
Results
The sample comprised 1,746 individuals with 1,571 UP
(90%) and 977 females (56%). At first presentation to
clinical services, the sample mean age was 17.8 years
(SD 3.4, median 17.5), with 33% of cases’ ages allocated
to the following age groups: 12 to 15, 16 to 19 and 20 to
25 years, respectively. The median score on the Kessler-
10 was 30, and on the WSAS, it was 20. Kessler-10
scores were statistically significantly correlated with
WSAS scores (r = 0.62, p = 0.001), and this correlation
remained statistically significant after controlling for
age, gender and diagnostic sub-type (r = 0.49, p = 0.003).
The sample median score for suicidal ideation was low
(0.42, on a 0 to 3 rating), but 7% of cases (n = 124)
expressed ideas of self-harm. Scores on the suicidal
ideation scale and Kessler Psychological Distress Scale
(K-10) were correlated (r = 0.51, p = 0.002), but there
was no significant association with age, gender or diag-
nostic sub-type. About 5% of cases (n = 87) had experi-
enced one or more psychotic symptoms, but again,
there were no statistically significant associations with
age, gender or diagnosis. Age at first consumption of alco-
hol, tobacco and cannabis was reported for only 962 of
the sample, but the median for all substances was similar
(about 14.5 years; 25th and 75th percentiles: 11 and
16 years, respectively), with females starting marginally
but not significantly later than males (median: females,
15 years; males 14.5 years). There was no evidence of any
differences in age at first substance use in sub-groups de-
fined according to age at presentation (12 to 15, 16 to 19
and 20 to 25 years) although a larger proportion of the
youngest age group had never consumed any of these
substances.
Data was available on Kessler-10 and WSAS scores for
1,640 individuals (580 male UP, 124 male BD, 815 female
UP and 121 female BD), allowing these cases to be
allocated to one of the four distress/impairment sub-
groups. Cases with high distress and high impairment
(Kessler-10 score >30, WSAS score >20) formed the lar-
gest group comprising 39% of this sample, with just under
a third of the sample classified in the high distress/low im-
pairment (15%) or low distress/high impairment (14%)
groups and the remainder (32%) categorised as having low
distress/low impairment (see Table 1). As shown in
Figure 1, the distribution of cases between the distress/
impairment groups differed significantly by gender and













(N = 527) (N = 247) (N = 223) (N = 643)
Mean age (SD) in years (n = 1,678)a 17.07 (3.45) 17.40 (2.95) 18.31 (3.69) 18.53 (3.02) F = 16.18 0.001
df = 3, 1,674
No vocational activity (n = 386) 81 (21%) 66 (17%) 54 (14%) 185 (48%) χ2 = 26.56 0.001
df = 6c
No lifetime co-morbidities (n = 512) 175 (33%) 75 (30%) 71 (33%)b 191 (29%) χ2 = 14.43 0.1
df = 9d
Nicotine abstinence (n = 894) 331 (63%) 134 (54%) 125 (58%)b 304 (47%) χ2 = 21.01 0.01
df = 3
Alcohol abstinence (n = 555) 216 (41%) 83 (34%) 89 (42%)b 167 (26%) χ2 = 24.93 0.01
df = 3
Cannabis abstinence (n = 1,177) 411 (78%) 177 (72%) 165 (77%)b 424 (66%) χ2 = 19.62 0.01
df = 3
Abstinence from substance
useb (n = 543)
217 (41%) 92 (37%) 87 (41%)b 147 (23%) χ2 = 38.27 0.001
df = 9d
aTotal cases = 1,678 due to missing data; n= 1,640 were assigned to distress/impairment groups (the remaining n= 38 cases had missing K-10 or WSAS scores). Numbers
included in each analysis are given in brackets; levels of distress and impairment were determined by K-10 and WSAS scores, respectively. Post hoc analysis shows that the
high impairment/distress group is significantly older than both low impairment groups; the high impairment/low distress group is also significantly older than the two low
impairment sub-groups (age of high distress groups do not differ significantly; ditto for the low impairment groups). bSubstance refers to alcohol, nicotine or cannabis. cThree
categories for vocational status. dFour sub-groups for co-morbidity and for poly-substance use (see the ‘Methods’ section for details).
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males (with UP or BD) allocated to the high distress
groups (irrespective of impairment level) and about the
same proportion of males (with UP or BD) classified as
having low levels of distress (irrespective of impairment).Figure 1 Distribution of cases of unipolar and bipolar disorders in male
WSAS and K-10.Individuals in the high distress/impairment group were
more likely to be older (F = 16.18; df = 3, 1,674; p =
0.001). Youth in this group were less likely to be in part-
time or full-time education, training or employment
(χ2 = 26.56, df = 6, p = 0.01), with almost 50% of thes and females across groups. Defined by high and low scores on the
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tional status was significantly influenced by age group,
with nearly all cases aged 12 to 15 years being in full-time
or part-time education and the majority of these cases
were allocated to the groups with the lowest levels of
impairment.
Co-morbid mental disorders (mainly anxiety or
developmental/behavioural disorders) were diagnosed in
over 65% cases (n = 1,187), but the prevalence and types
of problems were similar across the four distress/
impairment sub-groups. About a third of the sample
(544/1,669) reported total abstinence from substance use
(i.e. they had never used nicotine, alcohol or cannabis),
and a significantly greater proportion of these cases (217/
544; 40% of non-users) were allocated to the low distress/
low impairment group. In contrast, users of any or all
three substances (cannabis use = 29%, nicotine use = 47%,
alcohol use = 67%, poly-substance use = 23%) were over-
represented in the groups with high levels of distress, irre-
spective of their reported levels of impairment on the
WSAS.
As shown in Table 2, MNLR indicated that individuals
allocated to the high distress/low impairment group
were likely to be younger (OR for 12 to 15 age group,
3.14; 95% CI, 1.67 to 6.06) than those in the high distress/
impairment group. The variables that best differentiated
individuals with low distress/high impairment from the
high impairment/distress group were as follows: being
more likely to be male (OR, 2.05; 95% CI, 1.29 to 3.22)
and less likely to use nicotine, alcohol or cannabis (OR for
poly-substance use, 0.61; 95% CI, 0.44 to 0.83). In contrast,
the individuals in the low impairment/distress group were
significantly younger (OR for 12 to 15 age group, 3.72;
95% CI, 2.18 to 6.34), more likely to be male (OR, 2.20;
95% CI, 1.21 to 3.83) and being less likely to reportTable 2 Multinomial logistic regression






High distress and low impairment
Age 12 to 15 years 0.001 3.14 1.63 to 6.06
High impairment and low distress
Male 0.01 2.05 1.29 to 3.22
Poly-substance usea 0.003 0.61 0.44 to 0.85
Low impairment and low distress
Age 12 to 15 years 0.000 3.72 2.18 to 6.34
Male 0.001 2.20 1.21 to 3.83
Alcohol use 0.004 0.37 0.16 to 0.81
Cannabis use 0.004 0.27 0.19 to 0.45
Differences between the group with a high level of distress and impairment
(reference group) compared to groups defined by other combinations of high
or low levels of impairment and of distress are demonstrated. a‘Poly-substance
use’ refers to consumption of nicotine, alcohol and cannabis (see text
for details).cannabis (OR, 0.27; 95% CI, 0.19 to 0.45) or alcohol use
(OR, 0.37; 95% CI, 0.16 to 0.81). An additional analysis of
this latter group (available from the authors) that exam-
ined any interactions between gender and diagnosis
showed a greater probability that males with BD were es-
pecially likely to be categorised in the low distress/impair-
ment group rather than in the high distress/impairment
group (OR, 3.1; 95% CI, 2.01 to 9.74).
Finally, we briefly examined the association between
the rate of cannabis use by cases across the four dis-
tress/impairment sub-groups. Figure 2 shows the pro-
portion of individuals in each group using cannabis at
different frequencies (collapsed from five to three cat-
egories: less than monthly, less than weekly, daily or al-
most daily). The patterns of cannabis consumption
suggest that whilst infrequent use (one to two occasions)
does not differentiate between groups, consumption of
cannabis on a weekly basis is associated with a ‘dose-re-
sponse’ profile, whilst the highest levels of consumption
(daily or almost daily cannabis use) are associated with
the groups with the highest levels of impairment, irre-
spective of distress level.
Discussion
This study is one of the largest undertaken so far of a co-
hort of adolescents and young adults presenting for the
first time to youth mental health services with a primary
diagnosis of mood disorder. It is the first that tries to
understand the characteristics of groups defined by levels
of distress and disability at the time of presentation. Given
the age range of the study population, it is unsurprising
that 90% of cases are currently categorised as UP, as a
third of the study sample have not yet entered the period
of maximum risk for the onset of hypomanic or manic ep-
isodes (50% BD cases commence between 15 and 25 years),
and most of the rest of the cases have not completed their
transition through the peak age at the onset period. This
is important to remember when considering the findings,
especially with regard to the relative lack of differences in
levels of impairment and/or distress between UP and BD.
Further prospective follow-up is required to determine the
trajectories of mood disorders in this cohort, to observe
how many cases classified as UP later make a transition to
BD and to identify if distress, impairment or other param-
eters have predictive validity.
Another important study finding is that young people
with mood disorders presenting to youth mental health
services do not have ‘mild problems’. The mean and me-
dian scores of the distress (K-10) and functional ratings
(WSAS) suggest that they have levels of distress and im-
pairment that are comparable with those seen in youth
with other severe mental disorders, and distress levels
are similar to those reported in middle-aged and older
adults (Angst et al. 2010; Elhai and Ford 2007; Mojtabai
Figure 2 Frequency of cannabis use in the last 3 months. In groups defined according to high and low scores on the WSAS and K-10 scores.
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degree of substance use is reported by two thirds of the
sample - which is again similar to that seen in adult pop-
ulations with established mood disorders (Murphy et al.
2010). It was noteworthy that - as reported previously
(Hermens et al. 2013) - the first use of alcohol or other
substances preceded help-seeking for UP or BD by at
least 2 years in the majority of cases. Younger age seems
to be associated with marginally less functional impair-
ment (measured on the WSAS) than older adult popula-
tions (Murphy et al. 2010), but many of those studies
used different measures for impairment. However, even
within our youth sample, the youngest age group (12 to
15 years) showed the lowest levels of impairment (irre-
spective of distress level). However, it is not possible to
clarify if this is simply because they have been ill for a
shorter period of time (compared to their older peers),
because other people (e.g. teachers or parents) can be
more influential in initiating referrals and/or these indi-
viduals are less likely to have a substance use habit.
Clearly, these are important issues to disentangle in fu-
ture studies.
Diagnostic sub-type alone did not differentiate groups
defined according to high or low impairment or distress;
indeed, it was noticeable (see Figure 1) that male BD
cases were classified in the group with the lowest dis-
tress/impairment levels, whilst females with BD were
more likely to be categorised as highly distressed/im-
paired. The cross-sectional nature of the study and themeasures employed do not provide robust evidence as
to whether females are sicker than males at first clinical
presentation or that females delay help-seeking longer
than males. The latter is certainly not in keeping with
the published literature (Hickie et al. 2001; McGorry
et al. 2007; Scott et al. 2012) and so other explanations
need consideration. For example, the gender findings
could be an artefact of sampling, as it is conceivable that
females (even when highly distressed or impaired) are
more likely to agree to participate in research than
males. However, an alternative, more plausible interpret-
ation is that females are more likely to acknowledge the
degree of dysfunction caused by their symptoms or they
perceive that their symptoms and disability lead to more
severe levels of distress and impairment (thus scoring
higher on the rating scales employed).
Lastly, the groups with the highest versus the lowest
levels of distress/impairment were distinguished by the
use of cannabis and alcohol. Furthermore, a brief review
of Table 1 suggests that lower levels of distress (irre-
spective of impairment) were associated with abstinence
from alcohol, cannabis, nicotine or poly-substance use.
Along with the findings of the MLRN, it is indirect
evidence that substance use aggravates the initial clin-
ical presentation of a mood disorder. There was also
preliminary evidence that the frequency of consump-
tion (e.g. Figure 2 on the use of cannabis) was associated
with a dose–response effect on distress and impairment.
However, as there was limited data regarding the age at
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port this), it was decided that it was not appropriate to
analyse the additional significance of duration of sub-
stance use nor the issue of primacy (did substance use
precede mood disorders in the worst functioning/most
distressed groups) or was it a secondary phenomenon,
e.g. representing a maladaptive ‘coping’ style. This study
highlights the need for careful assessment of temporality
of the onset of mood disorders and substance use and
emphasises that any treatment strategies for youth pre-
senting with UP or BD need to be designed with a view to
their applicability to groups who have co-occurring sub-
stance use.
Finally, it is important to acknowledge the limitations
to this study. For example, we did not assess neuro-
psychological functioning or medical illnesses, both of
which may impair functioning or augment distress, nor
did we assess personality disorders, although the value
of assessment of these in younger adults is debatable,
especially in those aged 12 to 15 years or so. It is also
possible that young people with psychotic or manic
symptoms may be less likely to recognise or acknow-
ledge any functional impairment. However, these fea-
tures were present in only a minority of this sample, and
those with severe manic or psychotic symptoms would
be less able to consent to participate (or participation
would be delayed until insight had returned). Lastly, we
do not report medications in this paper - this is partly
because many young people were drug free at the time
of assessment, and those who were prescribed medica-
tions had often been on low doses of standard treat-
ments or had not been taking medication for very long;
also, non-adherence rates are high in youth (Tacchi and
Scott 2006). Taken altogether, this means that impair-
ment due to medication side effects was unlikely to be a
significant confounder in this study population, although
it is conceivable that lack of or low doses of medication
may mean that the level of acute distress at presentation
was higher than in more comprehensively medicated
samples.
Conclusions
In youth presenting with a mood disorder for the first
time, nearly four out of ten individuals reported high
levels of distress or disability, but about 30% of cases
were discordant (high distress/low impairment and
vice versa). Gender rather than diagnostic sub-type
was strongly associated with distress levels, whilst
older age showed a significant association with func-
tional impairment. Co-morbid mental disorders were
common but were not as important as alcohol and
substance use, especially regular cannabis use, as the
best predictors of distress and impairment. The major
implications of this study are as follows: (a) mooddisorders in youth are not mild problems and require
active treatment, and (b) the co-occurrence of sub-
stance use will complicate both the assessment of the
consequences of mood disorder for the individual and
the options for intervention.
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